You are here

Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Type Project # RFA # PI/Project Leader Institution Title Statussort ascending
2018 R21 CA228948 RFA-CA-17-010 SCHIBEL, ANNA ELECTRONIC BIOSCIENCES, INC. Microsatellite Sequencing to Enable Cancer Genotyping NCE
2017 R21 CA214233 RFA-CA-16-001 SOELLNER, MATTHEW B UNIVERSITY OF MICHIGAN AT ANN ARBOR Exquisitely selective turn-on probes of kinase activation and localization NCE
2017 R21 CA214299 RFA-CA-16-001 SLATER, JOHN HUNDLEY UNIVERSITY OF DELAWARE A Vascularized, In Vitro, Organotropic Metastasis Model to Generate Dormant Micrometastases NCE
2016 R21 CA191243 RFA-CA-15-004 SULCHEK, TODD GEORGIA INSTITUTE OF TECHNOLOGY LABEL-FREE MICROFLUIDIC ENRICHMENT OF CANCER CELLS FROM NONCANCER CELLS IN ASCITES FLUID NCE
2018 R21 CA223887 RFA-CA-17-010 SMITH, LLOYD M UNIVERSITY OF WISCONSIN-MADISON Novel NeuCode Tagging Reagents for Identification and Quantification of Intact Proteoforms in Cancer Tissues NCE
2018 R21 CA214239 RFA-CA-17-010 VAN DEVENTER, JAMES ALLEN TUFTS UNIVERSITY MEDFORD Discovering hybrid inhibitors for tumor microenvironment disruption NCE
2017 R21 CA217751 RFA-CA-16-003 NECHAEV, SERGEI UNIVERSITY OF NORTH DAKOTA Transcriptome profiling of highly degraded specimens through global analysis of short RNA fragments. NCE
2017 R21 CA217754 RFA-CA-16-001 DICKINSON, BRYAN UNIVERSITY OF CHICAGO rePPI-i: A system for the rapid continuous evolution of protein-protein interaction inhibitors NCE
2018 R33 CA223904 RFA-CA-17-011 CIMA, MICHAEL J MASSACHUSETTS INSTITUTE OF TECHNOLOGY Advanced development and validation of microdevices for high-throughput in situ drug sensitivity testing in tumors NCE
2018 R33 CA223908 RFA-CA-17-011 KONRY, TANIA TALI NORTHEASTERN UNIVERSITY Determining treatment sensitivity in B cell lymphoma by novel microfluidics-based NK cell immunogenicity platform NCE
2017 R33 CA206907 RFA-CA-16-004 ISSADORE, DAVID AARON UNIVERSITY OF PENNSYLVANIA Rapid unbiased isolation and in situ RNA analysis of circulating tumor cells using a magnetic micropore-based diagnostic chip NCE
2018 R33 CA225494 RFA-CA-17-011 LIU, YANG UNIVERSITY OF PITTSBURGH AT PITTSBURGH High-throughput super-resolution imaging of chromatin structures at different epigenetic states NCE
2017 R33 CA206939 RFA-CA-16-004 PATTENDEN, SAMANTHA GAIL UNIV OF NORTH CAROLINA CHAPEL HILL The application of Enhanced Cavitation to enable DNA and Chromatin Extraction from Archived Tissues NCE
2018 R33 CA225863 RFA-CA-17-011 LU, JUN YALE UNIVERSITY CRISPR-based Enhanced Molecular Chipper Technology for Identifying Functional Noncoding Elements in Cancer NCE
2016 R21 CA202804 RFA-CA-15-002 GAMCSIK, MICHAEL NORTH CAROLINA STATE UNIVERSITY RALEIGH HIGH-THROUGHPUT SCREENING UNDER STATIC OR DYNAMIC HYPOXIA NCE
2018 R33 CA222344 RFA-CA-17-011 SALIPANTE, STEPHEN J UNIVERSITY OF WASHINGTON Advanced development and validation of genome-scale molecular diagnostics for microsatelliteinstability using targeted molecular counting methods NCE
2017 R33 CA212806 RFA-CA-16-004 ZILBERBERG, JENNY HACKENSACK UNIVERSITY MEDICAL CENTER Ex vivo culture platform validation for preservation of patient derived multiple myeloma cells NCE
2016 R33 CA206955 RFA-CA-15-003 WEISS, GREGORY A. UNIVERSITY OF CALIFORNIA-IRVINE Monitoring Recurrent Bladder Cancer with Electro-Phage Biosensors NCE
2018 R21 CA225507 RFA-CA-17-012 PAULOVICH, AMANDA G FRED HUTCHINSON CANCER RESEARCH CENTER Validation of a disposable biospecimen collection system with integral refrigeration for preserving the phosphoproteome NCE
2016 R33 CA196470 RFA-CA-15-003 LIN, QIAO COLUMBIA UNIV NEW YORK MORNINGSIDE Validating Rapid Microfluidic Isolation of Personalized Aptamers for Monitoring Minimal Residual Disease in Multiple Myeloma NCE
2017 R33 CA217652 RFA-CA-16-002 MAKRIGIORGOS, G. MIKE DANA-FARBER CANCER INST Maximum efficiency sequencing using nuclease-based mutation enrichment and digital barcodes NCE
2017 R33 CA217699 RFA-CA-16-002 IBRAHIM, YEHIA BATTELLE PACIFIC NORTHWEST LABORATORIES High Resolution High Throughput Proteomics Platform for Cancer Research NCE
2017 R33 CA217700 RFA-CA-16-002 WALTER, MATTHEW J WASHINGTON UNIVERSITY TARGETED SINGLE-MOLECULE SEQUENCING ASSAY INCORPORATING MOLECULAR BARCODES NCE
2017 R33 CA217780 RFA-CA-16-002 PARKER, LAURIE L. UNIVERSITY OF MINNESOTA Fluorescence lifetime-based single fluorophore biosensors of post-translational modification enzyme activity NCE
2017 R21 CA212495 RFA-CA-16-001 EASWARAN, HARIHARAN JOHNS HOPKINS UNIVERSITY High-efficiency microfluidic-assisted single-cell DNA methylome sequencing NCE
2017 R21 CA212500 RFA-CA-16-001 MOHS, AARON M. UNIVERSITY OF NEBRASKA MEDICAL CENTER Tunable Fluorescent Organic Nanoparticles for Cancer Imaging Applications NCE
2017 R21 CA212726 RFA-CA-16-001 NAEGLE, KRISTEN M WASHINGTON UNIVERSITY A MOLECULAR TOOLKIT FOR THE PRODUCTION OF TYROSINE PHOSPHORYLATED PROTEINS NCE
2019 R43 CA236167 PAR-18-303 WARREN, CHRISTOPHER L PROTEOVISTA, LLC Development of the High Throughput APT-SNAP Platform for Rapid Identification ofNuclease-Resistant RNA Aptamers against p53 Missense Mutations NCE
2018 R21 CA223836 RFA-CA-17-010 FIELDS, RYAN C WASHINGTON UNIVERSITY Advancing Cancer Biology, Diagnostics and Therapeutics Outside of the Patient: Creation of a Novel, Autologous, Ex Vivo, Vascularized Model of the Tumor Microenvironment NCE
2017 R21 CA212907 RFA-CA-16-001 KARGINOV, ANDREI V UNIVERSITY OF ILLINOIS AT CHICAGO Engineered regulation of tyrosine phosphatase activity in living cells NCE
2017 R21 CA212928 RFA-CA-16-001 BROCK, AMY UNIVERSITY OF TEXAS, AUSTIN High resolution cell lineage tracking and isolation NCE
2018 R21 CA223915 RFA-CA-17-010 KARGINOV, ANDREI V UNIVERSITY OF ILLINOIS AT CHICAGO Optogenetic tools for the dissection of oncogenic signaling mediated by kinases NCE
2019 R21 CA223727 RFA-CA-18-002 HUANG, XIAOHUA UNIVERSITY OF CALIFORNIA, SAN DIEGO Technology for measuring telomere length of individual chromosomes of single cancer cells NCE
2018 R21 CA225474 RFA-CA-17-010 MEHTA, ANAND S MEDICAL UNIVERSITY OF SOUTH CAROLINA Glyco-typer: an antibody capture glycan imaging methodology NCE
2018 R21 CA223853 RFA-CA-17-010 ROBLES, FRANCISCO E GEORGIA INSTITUTE OF TECHNOLOGY Stimulated Raman scattering spectroscopic optical coherence tomography (SRS-SOCT) for label-free molecular imaging of brain tumor pathology NCE
2000 R33 CA083213 PAR-98-067 TOLIAS, PETER P PUBLIC HEALTH RESEARCH INSTITUTE FUNCTIONAL CLONING OF DNA AND RNA BINDING PROTEINS Complete
2002 R33 CA091216 PAR-99-102 ALLBRITTON, NANCY L UNIVERSITY OF CALIFORNIA IRVINE PROFILING RAS ACTIVATED SIGNAL TRANSDUCTION PATHWAYS Complete
2006 R21 CA118600 RFA-CA-06-002 LARGAESPADA, DAVID ANDREW UNIVERSITY OF MINNESOTA TWIN CITIES TRANSPOSON-BASED SOMATIC MUTAGENESIS/PROSTATE CANCER GENETICS Complete
2008 R43 CA132852 RFA-CA-07-041 MATHEW, ANU MESO SCALE DIAGNOSTICS, LLC MULTIPLEXED BIOMARKER PANELS FOR EARLY DETECTION OF PROSTATE CANCER Complete
2011 R43 CA163403 RFA-CA-10-013 RUAN, BIAO POTOMAC AFFINITY PROTEINS, LLC PROTEASE CHAIN REACTIONS FOR MOLECULAR ANALYSIS OF CANCER MARKERS Complete
2015 R43 CA193096 PAR-13-327 JIANG, LI A'AS, INC. KS-DETECT: A SOLAR-POWERED AND SMARTPHONE INTEGRATED INSTRUMENT FOR POINT-OF-CARE DIAGNOSIS OF KAPOSI'S SARCOMA Complete
2000 R21 CA084697 PAR-98-067 SHERRY, A. DEAN UNIVERSITY OF TEXAS DALLAS MRI AGENTS SENSITIVE TO BIOLOGICAL INDICATORS OF NEOPLAS Complete
2002 R21 CA092731 PAR-01-106 SESHI, BEERELLI LA BIOMED RES INST/ HARBOR UCLA MED CTR FUNCTIONAL PROTEOMICS OF LEUKEMIC MARROW STROMAL CELLS Complete
2005 R21 CA114489 RFA-CA-05-002 CLAFFEY, KEVIN P. UNIVERSITY OF CONNECTICUT SCH OF MED/DNT IDENTIFICATION OF IMMUNE SELECTED BREAST CANCER ANTIGENS Complete
2008 R21 CA134386 RFA-CA-07-033 SZMACINSKI, HENRYK UNIVERSITY OF MARYLAND BALTIMORE TIME-RESOLVED FLUOROMETRIC METHOD FOR ASSAY OF MULTIPLE BIOMARKERS Complete
2011 R21 CA151140 RFA-CA-10-003 BLAIR, SARAH L UNIVERSITY OF CALIFORNIA SAN DIEGO NON-CIRCULATING MICROPARTICLES FOR IMPROVED LOCALIZATION AND RESECTION CANCER Complete
2015 R21 CA193046 RFA-CA-14-003 HAYDEN, MELANIE STANFORD UNIVERSITY CELL-FREE TUMOR DNA IN CEREBRAL SPINAL FLUID DECODES TUMORS OF THE CENTRAL NERVOUS SYSTEM Complete
1999 R33 CA081662 PAR-98-067 CHALMERS, JEFFREY JOHN OHIO STATE UNIVERSITY RAPID RARE CANCER CELL ISOLATION FOR MOLECULAR DIAGNOSIS Complete
2001 R33 CA086248 PAR-99-102 DABORA, SANDRA L BRIGHAM AND WOMEN'S HOSPITAL MUTANT ANALYSIS OF TSC1 & TSC2 IN TSC RELATED DISORDERS Complete
2004 R21 CA101171 PAR-01-106 DOVICHI, NORMAN J UNIVERSITY OF WASHINGTON SINGLE CELL PROTEIN FINGERPRINTING - BARRETT'S ESOPHAGUS Complete

Pages



National Cancer Institute at the National Institutes of Health

 

NIH… Turning Discovery Into Health®